IGC Pharma, Inc 8-K 12-15-25 - IGC Pharma, INC.

SEC

Filings

December 15, 2025

IGC Pharma, Inc 8-K 12-15-25

IGC Pharma, Inc. IGC on NYSE

Related Posts

IGC Pharma, Inc. 424B5 01-06-26

January 6, 2026

IGC Pharma, Inc 8-K 01-06-26

January 6, 2026

IGC Pharma, Inc 8-K 01-02-26

January 2, 2026

CEO Update

IGC Pharma Expands Phase 2 CALMA Trial with New Clinical Trail Site at Integrative Clinical Trials in New York

January 22, 2026

IGC Pharma Expands Phase 2 CALMA Trial with New Clinical Site at Dominion Medical Associates, a Lightship network site, in Richmond, Virginia

January 12, 2026